Tag Archives: C. difficile Lab Test

Researchers Combined Efforts Will Hopefully Lead To Improved Recognition Of Clostridioides difficile Pathogen To Reduce the Suffering and Economic Losses Caused by a CDI

Clostridioides difficile Infection: The Challenge, Tests, and Guidelines



Clostridioides difficile is a dangerous human pathogen because it can grow to high numbers in the intestine, cause colitis with its potent toxins, and persist as spores. C. difficile infection (CDI) is the primary hospital-acquired infection in North America and Europe, and it now is a global disease. Even with newer laboratory tests, there still is confusion on accurately diagnosing this disease. Three guidelines from three different healthcare-affiliated societies have recently been published. Consensus consolidated recommendations from these guidelines should be recognized by healthcare professionals, who need to understand why this disease continues to be difficult to diagnose and need a clear understanding of the advantages and limitations of current tests. Hopefully, these combined efforts will lead to an improvement in the recognition of this pathogen and a reduction in the suffering and economic loss caused by CDI.




To review the publication in its entirety please click on the link below to be redirected:


Rapid Detection of a C. difficile Toxins Through Laboratory Testing Accelerates Diagnosis and Treatment



Clostridium difficile is an anaerobic, spore-forming and Gram-positive bacillus. It is the major cause of antibiotic-associated diarrhea prevailing in hospital settings. The morbidity and mortality of C. difficile infection (CDI) has increased significantly due to the emergence of hypervirulent strains.

Because of the poor clinical different between CDI and other causes of hospital-acquired diarrhea, laboratory test for C. difficile is an important intervention for diagnosis of CDI.


Laboratory tests for CDI can broadly detect either the organisms or its toxins. Currently, several laboratory tests are used for diagnosis of CDI, including

toxigenic culture,

glutamate dehydrogenase detection,

nucleic acid amplification testing, cell cytotoxicity assay,

and enzyme immunoassay towards toxin A and/or B.

This review focuses on the rapid testing of C. difficile toxins and currently available methods for diagnosis of CDI, giving an overview of the role that the toxins rapid detecting plays in clinical diagnosis of CDI.




C. difficile Laboratory Test Information For Patients and Healthcare Providers

Testing for Clostridium difficile toxin with real-time polymerase chain reaction (PCR) can improve the laboratory diagnoses of C difficile–associated diarrhea, compared with A/B enzyme immunoassay (EIA), according to results from a study presented at a Association for Molecular Pathology meeting.

In fact, real-time PCR demonstrated a sensitivity of 100% and a specificity of 96.9%, whereas the A/B EIA was found to generate both false-positive and false-negative results.

“Although C difficile–associated diarrhea has increased in prevalence and severity, the inaccuracy of conventional C difficile toxin EIA for diagnosis is well documented in the literature,” said lead investigator Cynthia Essmyer, MD, medical pathologist at Saint Luke’s Hospital in Kansas City, Missouri. (1)

The Microbiology Laboratory medical pathologist at a University Hospital located in NC shared the following information to answer one of the many questions:  “Why won’t the lab run a test on hard formed stool?”

The lab will not accept a stool specimen that is hard/formed stool due to the fact that the PCR test is regulated by the testing company and a hard/formed stool can produce a false positive result.  Soft, unformed or watery stools are all accepted for the PCR testing.

  • ACCEPTABLE SPECIMEN: FecesCollect specimen as follows:
    1. Collect feces in a clean, dry container or bedpan not contaminated with urine, residual soap, or disinfectants.
    2. Transfer appropriate volume of feces to a clean dry tightly capped specimen cup.
    3. Submit double-bagged specimen cup immediately to laboratory.
  • NOTES:
    1. Patients should be passing at least 3 unformed or watery stool specimens in a 24-hour period. Most patients have more than 3 episodes of watery unformed stools per day.
    2. Soft specimen is defined as specimen assuming the shape of its container (unformed).
    3. Formed or hard fecal specimens will not be tested.
    4. Repeat testing following a negative test during the same episode of diarrhea is NOT recommended for at least 7-days because of high sensitivity (between 98-99% and with a 99% negative predictive value).

* There may be an alternate send out micro. test for hard formed stool and this information can be obtained at the laboratory being utilized.  Have a healthcare provider contact the lab prior to delivering a specimen to the lab location.

When a PCR result is NEGATIVE: the Wait time between testing is 7 days to retest.

When a PCR result is POSITIVE: the Wait time between testing is 14 days to retest.

Q:  Is there a wait time after completing antibiotic treatment (greater than 14 days since first positive result) to retest?
A:  No, since the PCR is testing micro-organisms the antibiotic will not interfere with testing.


Q:  Can a stool specimen be kept in a refrigerator and if so for how long?

REFRIGERATE IF TRANSPORT IS DELAYED. Specimens can be stored at 2-8 degrees C for 24 hours before significant degredation of the toxin is noted. SUBMIT WITH COLD PACKS OR ON ICE IF TRANSPORT WILL TAKE > 1 HOUR.

A specimen can be rejected by the lab if Specimen is received > 2 hours after collection unless submitted on ice or cold pack or with note that specimen stored in refrigerator prior to transport.

Q:  How long does it take to receive lab results?

A:  Routine turn around time is one day.



Source: (1) Medscape

other:  University Hospital Microbiology Laboratory in NC